EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 54 / No 1 (March 2022) J Extra Corpor Technol, 54 1 (2022) 79-82 References
Free Access
Issue
J Extra Corpor Technol
Volume 54, Number 1, March 2022
Page(s) 79 - 82
DOI https://doi.org/10.1051/ject/202254079
Published online 15 March 2022
  1. Shekar K, Badulak J, Peek G, et al. Extracorporeal life support organization COVID-19 interim guidelines. ASAIO J. 2020;66:707–21. [CrossRef] [PubMed] [Google Scholar]
  2. Extracorporeal Life Support Organization (ELSO) General Guidelines for all ECLS Cases. 2017. Available at: https://www.elso.org/Portals/0/ELSO%20Guidelines%20General%20All%20ECLS%20Version%201_4.pdf. Accessed July 5, 2021. [Google Scholar]
  3. Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378:1965–75. [CrossRef] [PubMed] [Google Scholar]
  4. Goligher EC, Tomlinson G, Hajage D, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome and posterior probability of mortality benefit in a post hoc Bayesian analysis of a randomized clinical trial. JAMA. 2018;320:2251–59. [CrossRef] [PubMed] [Google Scholar]
  5. Combes A, Peek GJ, Hajage D, et al. ECMO for severe ARDS: Systematic review and individual patient data meta-analysis. Intensive Care Med. 2020;46:2048–57. [CrossRef] [PubMed] [Google Scholar]
  6. Giraud R, Legouis D, Assouline B, et al. Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients. Physiol Rep. 2021;9:e14715. [Google Scholar]
  7. Dreier E, Malfertheiner MV, Dienemann T, et al. ECMO in COVID-19–prolonged therapy needed? A retrospective analysis of outcome and prognostic factors. Perfusion. 2021;36:582–91. [CrossRef] [PubMed] [Google Scholar]
  8. Loyalka P, Cheema FH, Rao H, et al. Early usage of extracorporeal membrane oxygenation in the absence of invasive mechanical ventilation to treat COVID-19-related hypoxemic respiratory failure. ASAIO J. 2021;67:392–94. [CrossRef] [PubMed] [Google Scholar]
  9. Li X, Hu M, Zheng R, et al. Delayed initiation of ECMO is associated with poor outcomes in patients with severe COVID-19: A multicenter retrospective cohort study. Front Med (Lausanne). 2021. doi:10.3389/fmed.2021.716086; published online September 16. [Google Scholar]
  10. Schünemann HJ, Khabsa J, Solo K, et al. Ventilation techniques and risk for transmission of coronavirus disease, including COVID-19: A living systematic review of multiple streams of evidence. Ann Intern Med. 2020. doi:10.7326/M20-2306; published online May 22. [Google Scholar]
  11. Yang X, Cai S, Luo Y, et al. Extracorporeal membrane oxygenation for coronavirus disease 2019-induced acute respiratory distress syndrome: A multicenter descriptive study. Crit Care Med. 2020;48:1289–95. [CrossRef] [PubMed] [Google Scholar]
  12. Uemura T, Matsuda W, Ogawa T. Concerns about the timing and settings of initiating extracorporeal membrane oxygenation in patients with severe coronavirus disease 2019 pneumonia. Crit Care Med. 2020;48:1357–8. [Google Scholar]
  13. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet. 2009;374:1351–63. [CrossRef] [Google Scholar]
  14. Steimer DA, Hernandez O, Mason DP, et al. Timing of ECMO initiation impacts survival in influenza-associated ARDS. Thorac Cardiovasc Surg. 2019;67:212–15. [CrossRef] [PubMed] [Google Scholar]
  15. Alhazzani W, Møller MH, Arabi YM, et al. . Surviving sepsis campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med. 2020;46:854–87. [Google Scholar]
  16. Neto AS, Deliberato RO, Johnson AE, et al. Mechanical power of ventilation is associated with mortality in critically ill patients: An analysis of patients in two observational cohorts. Intensive Care Med. 2018;44:1914–22. [CrossRef] [PubMed] [Google Scholar]
  17. Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation for COVID-19: Evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet. 2021;398:1230–8. [CrossRef] [Google Scholar]
  18. Lebreton G, Schmidt M, Ponnaiah M, et al. Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: A multicentre cohort study. Lancet Respir Med. 2021;9:851–62. [CrossRef] [Google Scholar]
  19. Grant AA, Hart VJ, Lineen EB, et al. A weaning protocol for venovenous extracorporeal membrane oxygenation with a review of the literature. Artif Organs. 2018;42:605–10. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.